{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:27:27Z","timestamp":1760660847895,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutritional Biochemistry"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jnutbio.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,10,3]],"date-time":"2014-10-03T19:23:34Z","timestamp":1412364214000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR mice by suppressing fatty acid desaturases"],"prefix":"10.1016","volume":"26","author":[{"given":"Sarah W.","family":"Njoroge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Laposata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelli L.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam C.","family":"Seegmiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9678","key":"10.1016\/j.jnutbio.2014.09.001_bb0005","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"issue":"4922","key":"10.1016\/j.jnutbio.2014.09.001_bb0010","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jnutbio.2014.09.001_bb0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-3476(62)80065-1","article-title":"The fatty acid composition of the serum chylomicrons and adipose tissue of children with cystic fibrosis of the pancreas","volume":"60","author":"Kuo","year":"1962","journal-title":"J Pediatr"},{"issue":"5\u20136","key":"10.1016\/j.jnutbio.2014.09.001_bb0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.plefa.2007.10.009","article-title":"Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis","volume":"77","author":"Al-Turkmani","year":"2007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jnutbio.2014.09.001_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.nutr.27.061406.093625","article-title":"Cystic fibrosis and nutrition: linking phospholipids and essential fatty acids with thiol metabolism","volume":"28","author":"Innis","year":"2008","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"10.1016\/j.jnutbio.2014.09.001_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.plefa.2010.07.002","article-title":"Fatty acid metabolism in cystic fibrosis","volume":"83","author":"Strandvik","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"10.1016\/j.jnutbio.2014.09.001_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00445666","article-title":"Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency","volume":"141","author":"Rogiers","year":"1983","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.jnutbio.2014.09.001_bb0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1165\/rcmb.2008-0279OC","article-title":"Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide","volume":"41","author":"Guilbault","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.jnutbio.2014.09.001_bb0045","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1067\/mpd.2001.118890","article-title":"Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis","volume":"139","author":"Strandvik","year":"2001","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jnutbio.2014.09.001_bb0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.arbres.2009.11.001","article-title":"Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis","volume":"46","author":"Olveira","year":"2010","journal-title":"Arch Bronconeumol"},{"issue":"6","key":"10.1016\/j.jnutbio.2014.09.001_bb0055","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000114208","article-title":"Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients","volume":"51","author":"Van Biervliet","year":"2007","journal-title":"Ann Nutr Metab"},{"issue":"5","key":"10.1016\/j.jnutbio.2014.09.001_bb0060","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/MPG.0b013e31817fb76b","article-title":"Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis","volume":"47","author":"Maqbool","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.jnutbio.2014.09.001_bb0205","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1194\/jlr.P013722","article-title":"Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients","volume":"52","author":"Ollero","year":"2011","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.jnutbio.2014.09.001_bb0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1586\/14737159.7.4.407","article-title":"What have we learned from mouse models for cystic fibrosis?","volume":"7","author":"Carvalho-Oliveira","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"10.1016\/j.jnutbio.2014.09.001_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2006-0184TR","article-title":"Cystic fibrosis mouse models","volume":"36","author":"Guilbault","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"Suppl 2","key":"10.1016\/j.jnutbio.2014.09.001_bb0080","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1016\/S1569-1993(11)60020-9","article-title":"Mouse models of cystic fibrosis: phenotypic analysis and research applications","volume":"10","author":"Wilke","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"24","key":"10.1016\/j.jnutbio.2014.09.001_bb0210","doi-asserted-by":"crossref","first-page":"13995","DOI":"10.1073\/pnas.96.24.13995","article-title":"A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(\u2212\/\u2212) mice","volume":"96","author":"Freedman","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.jnutbio.2014.09.001_bb0090","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.metabol.2006.05.002","article-title":"Evidence of increased flux to n-6 docosapentaenoic acid in phospholipids of pancreas from cftr\u2212\/\u2212 knockout mice","volume":"55","author":"Ollero","year":"2006","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.jnutbio.2014.09.001_bb0095","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3945\/jn.109.110999","article-title":"Increased tissue arachidonic acid and reduced linoleic acid in a mouse model of cystic fibrosis are reversed by supplemental glycerophospholipids enriched in docosahexaenoic acid","volume":"139","author":"Mimoun","year":"2009","journal-title":"J Nutr"},{"issue":"5","key":"10.1016\/j.jnutbio.2014.09.001_bb0215","doi-asserted-by":"crossref","first-page":"L599","DOI":"10.1152\/ajplung.00346.2009","article-title":"Linoleic acid supplementation results in increased arachidonic acid and eicosanoid production in CF airway cells and in cftr\u2212\/\u2212 transgenic mice","volume":"299","author":"Zaman","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.jnutbio.2014.09.001_bb0220","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3945\/jn.110.134585","article-title":"(n-3) long-chain PUFA differentially affect resistance to Pseudomonas aeruginosa infection of male and female cftr\u2212\/\u2212 mice","volume":"141","author":"Tiesset","year":"2011","journal-title":"J Nutr"},{"issue":"3","key":"10.1016\/j.jnutbio.2014.09.001_bb0110","doi-asserted-by":"crossref","first-page":"G839","DOI":"10.1152\/ajpgi.00582.2005","article-title":"Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis","volume":"292","author":"Beharry","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"10.1016\/j.jnutbio.2014.09.001_bb0225","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1194\/jlr.M700388-JLR200","article-title":"Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism","volume":"49","author":"Andersson","year":"2008","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.jnutbio.2014.09.001_bb0230","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1194\/jlr.M800035-JLR200","article-title":"A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA","volume":"49","author":"Al-Turkmani","year":"2008","journal-title":"J Lipid Res"},{"issue":"7\u20138","key":"10.1016\/j.jnutbio.2014.09.001_bb0125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbalip.2011.05.002","article-title":"Increased Delta5- and Delta6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis","volume":"1811","author":"Njoroge","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.jnutbio.2014.09.001_bb0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11745-011-3563-z","article-title":"Increased elongase 6 and Delta9-desaturase activity are associated with n-7 and n-9 fatty acid changes in cystic fibrosis","volume":"46","author":"Thomsen","year":"2011","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.jnutbio.2014.09.001_bb0235","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1194\/jlr.M018101","article-title":"DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activity","volume":"53","author":"Njoroge","year":"2012","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.jnutbio.2014.09.001_bb0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11745-013-3768-4","article-title":"Interactions of linoleic and alpha-linolenic acids in the development of fatty acid alterations in cystic fibrosis","volume":"48","author":"Katrangi","year":"2013","journal-title":"Lipids"},{"issue":"2 Pt 1","key":"10.1016\/j.jnutbio.2014.09.001_bb0145","doi-asserted-by":"crossref","first-page":"C442","DOI":"10.1152\/ajpcell.1997.273.2.C442","article-title":"Immuno and functional characterization of CFTR in submandibular and pancreatic acinar and duct cells","volume":"273","author":"Zeng","year":"1997","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.jnutbio.2014.09.001_bb0240","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2260621","article-title":"A new, rapid, method for preparation of dispersed pancreatic acini","volume":"226","author":"Bruzzone","year":"1985","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.jnutbio.2014.09.001_bb0155","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"issue":"5073","key":"10.1016\/j.jnutbio.2014.09.001_bb0160","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1126\/science.257.5073.1083","article-title":"An animal model for cystic fibrosis made by gene targeting","volume":"257","author":"Snouwaert","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jnutbio.2014.09.001_bb0165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.2002.tb04275.x","article-title":"Desaturation and elongation of fatty acids and insulin action","volume":"967","author":"Vessby","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.jnutbio.2014.09.001_bb0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0005-2760(91)90254-F","article-title":"Peroxisomal retroconversion of docosahexaenoic acid (22:6(n-3)) to eicosapentaenoic acid (20:5(n-3)) studied in isolated rat liver cells","volume":"1081","author":"Gronn","year":"1991","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.jnutbio.2014.09.001_bb0175","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/ajcn\/64.4.577","article-title":"Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols","volume":"64","author":"Brossard","year":"1996","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.jnutbio.2014.09.001_bb0180","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s004310050750","article-title":"Essential fatty acid deficiency in well nourished young cystic fibrosis patients","volume":"156","author":"Roulet","year":"1997","journal-title":"Eur J Pediatr"},{"issue":"5","key":"10.1016\/j.jnutbio.2014.09.001_bb0185","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1203\/PDR.0b013e3181b4e8d3","article-title":"Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy","volume":"66","author":"Aldamiz-Echevarria","year":"2009","journal-title":"Pediatr Res"},{"issue":"11","key":"10.1016\/j.jnutbio.2014.09.001_bb0190","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11745-004-1333-0","article-title":"Mechanisms of regulation of gene expression by fatty acids","volume":"39","author":"Nakamura","year":"2004","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.jnutbio.2014.09.001_bb0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.plefa.2007.12.005","article-title":"Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients","volume":"78","author":"Van Biervliet","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"2","key":"10.1016\/j.jnutbio.2014.09.001_bb0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.plefa.2012.10.002","article-title":"A randomized placebo-controlled study on high-dose oral algal decosahexaenoic acid supplementation in children with cystic fibrosis","volume":"88","author":"Alicandro","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"}],"container-title":["The Journal of Nutritional Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095528631400196X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095528631400196X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:14:56Z","timestamp":1760627696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095528631400196X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S095528631400196X"],"URL":"https:\/\/doi.org\/10.1016\/j.jnutbio.2014.09.001","relation":{},"ISSN":["0955-2863"],"issn-type":[{"type":"print","value":"0955-2863"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR\u2212\/\u2212 mice by suppressing fatty acid desaturases","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutritional Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnutbio.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}